Propel Bio Management, LLC Milestone Pharmaceuticals Inc. Transaction History
Propel Bio Management, LLC
- $82.4 Billion
- Q2 2025
A detailed history of Propel Bio Management, LLC transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Propel Bio Management, LLC holds 1,791,557 shares of MIST stock, worth $3.14 Million. This represents 4.22% of its overall portfolio holdings.
Number of Shares
1,791,557
Previous 1,451,557
23.42%
Holding current value
$3.14 Million
Previous $1.16 Billion
199.26%
% of portfolio
4.22%
Previous 1.35%
Shares
2 transactions
Others Institutions Holding MIST
# of Institutions
51Shares Held
16.8MCall Options Held
160KPut Options Held
34.8K-
Black Rock Inc. New York, NY4.97MShares$8.7 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY2.51MShares$4.39 Million0.07% of portfolio
-
Alta Fundamental Advisers LLC New York, NY1.4MShares$2.45 Million1.22% of portfolio
-
Bml Capital Management, LLC Zionsville, IN1.14MShares$1.99 Million1.67% of portfolio
-
Simplify Asset Management Inc. New York, NY990KShares$1.73 Million0.11% of portfolio
About Milestone Pharmaceuticals Inc.
- Ticker MIST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,010,900
- Market Cap $52.5M
- Description
- Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...